You're barking up the wrong tree. The person I'm referring to is a private investor and not affiliated with Dominion or any other firm.
Lots of things about to converge given what's happened over the past year. I still believe the company will be able to uplist without or with only a small RS.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links